Intra-Tympanic Steroid Injection and Keeping Specified Head position for facial nerve palsy

Intra-Tympanic Steroid Injection and Keeping Specified Head position for facial nerve palsy - i-Siks for facial palsy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049440

Enrollment

Registered

2022-11-06

Start date

2022-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral facial palsy including Bell&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with peripheral facial palsy and receiving systemic steroids who meet the following conditions and have a potentially poor prognosis; Yanagihara score of 8 or less and House-Brackmann grade 5 or higher, or Yanagihara score of 10-18 and House-Brackmann grade 4 without stapes reflex Patients diagnosed with peripheral facial palsy who are at high risk of complications from steroid administration due to their general condition or comorbidities and for whom systemic administration is not possible

Exclusion criteria

Exclusion criteria: Patients with a history of hypersensitivity to dexamethasone Patients with morphological abnormalities or severe infection of the external auditory canal or middle ear

Design outcomes

Primary

Measure	Time frame
Yanagihara's score, House-Brackmann grade and recovery rate 1 year after this therapy	—

Secondary

Measure	Time frame
Time it takes for signs of improvement to begin Time it takes for the disease to recover completely Incidence of adverse events	—

Countries

Japan

Contacts

Public ContactRie Kanai

Tazuke Kofukai Medical Research Institute Kitano Hospital Department of Otolaryngology, Head & Neck Surgery

r-kanai@kitano-hp.or.jp0663121221

Outcome results